文献速递妇科

机械性或热诱导子宫内膜-肌层界面破坏所致小鼠子宫腺肌病及其可能的预防

Adenomyosis in mice resulting from mechanically or thermally induced endometrial-myometrial interface disruption and its possible prevention.
PubMed 文献 · Reprod Biomed Online · 2020-07-29

研究纳入106只雌性BALB/c和12只雌性C57BL/6小鼠,开展6项前瞻性随机对照实验,评估机械性或不同强度电凝热诱导子宫内膜-肌层界面破坏后子宫腺肌病的发生率,并观察围术期给予阿瑞匹坦、普萘洛尔或溶媒的影响。机械性破坏后3个月多数小鼠发生子宫腺肌病而对照组未发生;热诱导破坏后10周发生率为30%,扩大破坏范围后升至66.7%;围术期阿瑞匹坦或普萘洛尔使发生率从100%降至58.3%。

要点

  • 机械性子宫内膜-肌层界面破坏后3个月,C57BL/6小鼠子宫腺肌病发生率为83.3%(P=0.015),BALB/c小鼠为100%(P=0.0002),对照组未发生。
  • 热诱导界面破坏后10周子宫腺肌病发生率为30%,扩大破坏范围后升至66.7%。
  • 围术期阿瑞匹坦或普萘洛尔使子宫腺肌病发生率从100%降至58.3%(均P=0.00034)。

核心结论

  • 本研究首次提供实验证据表明,医源性子宫操作导致的子宫内膜-肌层界面破坏可大幅增加子宫腺肌病发生风险,且风险与破坏严重程度成比例。
  • 围术期给予NK1R拮抗剂或β受体阻滞剂可显著降低子宫腺肌病发生风险。

研究设计与样本

  • 共开展6项前瞻性随机对照实验,纳入106只雌性BALB/c小鼠和12只雌性C57BL/6小鼠。
  • 在两种品系小鼠中评估机械性诱导或不同强度电凝热诱导子宫内膜-肌层界面破坏后子宫腺肌病的发生率。
  • 最后评估围术期给予阿瑞匹坦(NK1R抑制剂)、普萘洛尔(β受体阻滞剂)或溶媒的小鼠子宫腺肌病发生率。
  • 评估指标包括体重、热板潜伏期和肌层浸润分级,并进行组织学、免疫组化和组织化学分析。

主要发现

  • 机械性损伤子宫内膜-肌层界面造成界面破坏;机械性破坏后3个月,界面破坏组多数小鼠发生子宫腺肌病,对照组未发生(C57BL/6小鼠83.3%,P=0.015;BALB/c小鼠100%,P=0.0002)。
  • 热诱导界面破坏后10周,30%的界面破坏小鼠发生子宫腺肌病;扩大界面破坏范围后发生率增至66.7%。
  • 围术期给予阿瑞匹坦或普萘洛尔的小鼠,子宫腺肌病发生率从100%降至58.3%(均P=0.00034)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do uterine procedures potentially disrupting the endometrial-myometrial interface (EMI) induce adenomyosis? DESIGN: Six prospective, randomized controlled experiments were conducted involving a total of 106 female BALB/c and 12 female C57BL/6 mice. The incidence of adenomyosis was evaluated in these two strains of mouse after mechanically induced EMI disruption (EMID), or thermally induced EMID using electrocoagulation of different intensities. Finally, the incidence was evaluated in mice that had received perioperative administration of aprepitant (an NK1R inhibitor), propranolol (a beta-blocker) or vehicle. Body weight, hot plate latency and grade of myometrial infiltration were evaluated. Histology, immunohistochemistry and histochemistry analyses were also performed. RESULTS: Mechanical injury to the EMI caused EMID. Adenomyosis developed in the majority of mice in the EMID groups 3 months after mechanically induced EMID but did not develop in the control group (83.3% in C57BL/6 mice, P = 0.015; 100% in BALB/c mice, P = 0.0002). With thermally induced EMID, adenomyosis was found in 30% of the EMID mice 10 weeks later, but the incidence increased to 66.7% if the extent of EMID damage was increased. In mice with perioperative administration of aprepitant or propranolol, the incidence of adenomyosis was reduced from 100% to 58.3% (both P = 0.00034). CONCLUSIONS: This study provides the first piece of experimental evidence that EMID resulting from iatrogenic uterine procedures can substantially increase the risk of developing adenomyosis, with the risk in proportion to the severity of disruption. More intriguingly, perioperative administration of an NK1R antagonist or beta-blocker significantly reduced the risk of developing adenomyosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hao M, Liu X, Guo SW, et al. Adenomyosis in mice resulting from mechanically or thermally induced endometrial-myometrial interface disruption and its possible prevention. Reprod Biomed Online. 2020. PMID: 32921577. doi:10.1016/j.rbmo.2020.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。